Back
Speaker illustration

Doctor Carlos Iribarren

Kaiser Permanente of Northern California, Oakland (United States of America)

Carlos Iribarren MD, MPH, PhD, is a Research Scientist-III at the Kaiser Permanente Northern California Division of Research and an adjunct Assistant Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). He joined the Division of Research in 1997 and started at UCSF in 1998. Dr. Iribarren's current research interests include risk stratification in the primary prevention setting, including genomic, imaging (particularly breast arterial calcification), and blood biomarkers and the epidemiology of ECG traits (particularly QT interval) and chronic lung disease (COPD, asthma, interstitial pulmonary fibrosis). Dr. Iribarren was a standing member and co-chair of the NIH Cardiovascular, Heart and Sleep Study Section (CHS-B) from 2017-2021 and has participated in numerous other study sections, such as the American Heart Association Behavioral Science, Epidemiology. Dr. Iribarren has published over 220 peer-reviewed articles.

Presentations

Joint consideration of LDL-C and polygenic risk for incident coronary heart disease in a multi-ethnic cohort of 48,881 individuals

Event: ESC Preventive Cardiology 2024

Topic: Scores

Session: New factors and mechanisms explaining cardiovascular risk development

Access
Thumbnail

Utility of a polygenic risk score for incident CHD: interplay with lifestyle in a multi-ethnic cohort of more than 60,000 individuals

Event: ESC Congress 2023

Topic: Scores

Session: Cardiovascular risk assessment: scores (2)

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb